Embryonic stem cell transplantation: Promise and progress in the treatment of heart disease

BioDrugs

Volumn 22, Issue 6, 2008, Pages 361-374

  Zhang, Feixiong ^a   Pasumarthi, Kishore B S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cardiovascular disorders, general; Research and development; Stem cell therapies, general

Indexed keywords

ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; CARDIAC ELECTROPHYSIOLOGY; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 56049113264     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/0063030-200822060-00003     Document Type: Review

References (153)

1. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res 2002; 90 (10): 1044-54
2. McMullen NM, Gaspard GJ, Pasmarthi KB. Reactivation of cardiomyocyte cell cycle: a potential approach for myocardial regeneration. Signal Transduction 2005; 5 (3): 126-41
3. Statistics Canada. Causes of death 2002. Ottawa: Statistics Canada, 2004 [online]. Available from URL: http://www.statcan.ca/english/freepub/84-208-XIE/ 84-208-XIE2004002.htm [Accessed 2008 Jul 28]
4. Lloyd-Jones DM. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep 2001; 3 (3): 184-90
5. Guyatt GH, Devereaux PJ. A review of heart failure treatment. Mt Sinai J Med 2004; 71 (1): 47-54
6. Braunwald E, Antman EM. Evidence-based coronary care. Ann Intern Med 1997; 126 (7): 551-3
7. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352 (3): 225-37
8. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345 (20): 1435-43
9. McMullen NM, Pasumarthi KB. Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies? Can J Physiol Pharmacol 2007; 85 (1): 1-15
10. Hagege AA, Marolleau JP, Vilquin JT, et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006; 114 (1 Suppl.): I108-13
11. Balsam LB, Robbins RC. Haematopoietic stem cells and repair of the ischaemic heart. Clin Sci (Lond) 2005; 109 (6): 483-92
12. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 112 (20): 3174-83
13. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007; 450 (7171): 819-24
14. Li RK, Weisel RD, Mickle DA, et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg 2000; 119 (1): 62-8
15. Leor J, Patterson M, Quinones MJ, et al. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat: a potential method for repair of infarcted myocardium? Circulation 1996; 94 (9 Suppl.): II332-6
16. Rubart M, Pasumarthi KB, Nakajima H, et al. Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res 2003; 92 (11): 1217-24
17. Etzion S, Battler A, Barbash IM, et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001; 33 (7): 1321-30
18. Sakakibara Y, Nishimura K, Tambara K, et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 2002; 124 (1): 50-6
19. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78 (12): 7634-8
20. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292 (5819): 154-6
21. Doetschman T, Williams P, Maeda N. Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev Biol 1988; 127 (1): 224-7
22. Wheeler MB. Development and validation of swine embryonic stem cells: a review. Reprod Fertil Dev 1994; 6 (5): 563-8
23. Prelle K, Vassiliev IM, Vassilieva SG, et al. Establishment of pluripotent cell lines from vertebrate species: present status and future prospects. Cells Tissues Organs 1999; 165 (3-4): 220-36
24. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A 1995; 92 (17): 7844-8
25. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts [published erratum appears in: Science 1998; 282 (5395): 1827]. Science 1998; 282 (5391): 1145-7
26. Pasumarthi KB, Field LJ. Cardiomyocyte enrichment in differentiating ES cell cultures: strategies and applications. Methods Mol Biol 2002; 185: 157-68
27. Nichols J, Evans EP, Smith AG. Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 1990; 110 (4): 1341-8
28. Amit M, Itskovitz-Eldor J. Feeder-free culture of human embryonic stem cells. Methods Enzymol 2006; 420: 37-49
29. Doetschman TC, Eistetter H, Katz M, et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985; 87: 27-45
30. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005; 23 (7): 845-56
31. Das S, Bonaguidi M, Muro K, et al. Generation of embryonic stem cells: limitations of and alternatives to inner cell mass harvest. Neurosurg Focus 2008; 24 (3-4): E4
32. Pralong D, Mrozik K, Occhiodoro F, et al. A novel method for somatic cell nuclear transfer to mouse embryonic stem cells. Cloning Stem Cells 2005; 7 (4): 265-71
33. Tamada H, Kikyo N. Nuclear reprogramming in mammalian somatic cell nuclear cloning. Cytogenet Genome Res 2004; 105 (2-4): 285-91
34. Klimanskaya I, Chung Y, Becker S, et al. Human embryonic stem cell lines derived from single blastomeres. Nature 2006; 444 (7118): 481-5
35. Chung Y, Klimanskaya I, Becker S, et al. Embryonic and extra-embryonic stem cell lines derived from single mouse blastomeres. Nature 2006; 439 (7073): 216-9
36. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131 (5): 861-72
37. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318 (5858): 1917-20
38. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451 (7175): 141-6
39. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126 (4): 663-76
40. Pera MF. Stem cells: a new year and a new era. Nature 2008; 451 (7175): 135-6
41. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001; 108 (3): 407-14
42. Klug MG, Soonpaa MH, Koh GY, et al. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996; 98 (1): 216-24
43. Wobus AM, Wallukat G, Hescheler J. Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 1991; 48 (3): 173-82
44. Mummery C. Genetic selection of cardiomyocytes from human embryonic stem cells. Mol Ther 2007; 15 (11): 1908-9
45. Siu CW, Moore JC, Li RA. Human embryonic stem cell-derived cardiomyocytes for heart therapies. Cardiovasc Hematol Disord Drug Targets 2007; 7 (2): 145-52
46. Boheler KR, Czyz J, Tweedie D, et al. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 2002; 91 (3): 189-201
47. Maltsev VA, Wobus AM, Rohwedel J, et al. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 1994; 75 (2): 233-44
48. Mummery C, Ward D, van den Brink CE, et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 2002; 200 (Pt 3): 233-42
49. Muller M, Fleischmann BK, Selbert S, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. Faseb J 2000; 14 (15): 2540-8
50. Wobus AM, Kaomei G, Shan J, et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997; 29 (6): 1525-39
51. Hescheler J, Fleischmann BK, Lentini S, et al. Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Cardiovasc Res 1997; 36 (2): 149-62
52. Banach K, Halbach MD, Hu P, et al. Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am J Physiol Heart Circ Physiol 2003; 284 (6): H2114-23
53. Cui L, Johkura K, Takei S, et al. Structural differentiation, proliferation, and association of human embryonic stem cell-derived cardiomyocytes in vitro and in their extracardiac tissues. J Struct Biol 2007; 158 (3): 307-17
54. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22 (10): 1282-9
55. Guo XM, Zhao YS, Chang HX, et al. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 2006; 113 (18): 2229-37
56. Naito H, Melnychenko I, Didie M, et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006; 114 (1 Suppl.): I72-8
57. Wang X, Wei G, Yu W, et al. Scalable producing embryoid bodies by rotary cell culture system and constructing engineered cardiac tissue with ES-derived cardiomyocytes in vitro. Biotechnol Prog 2006; 22 (3): 811-8
58. Bauwens C, Yin T, Dang S, et al. Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: oxygen-mediated enhancement of cardiomyocyte output. Biotechnol Bioeng 2005; 90 (4): 452-61
59. Schroeder M, Niebruegge S, Werner A, et al. Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng 2005; 92 (7): 920-33
60. Zandstra PW, Bauwens C, Yin T, et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 2003; 9 (4): 767-78
61. Sauer H, Rahimi G, Hescheler J, et al. Role of reactive oxygen species and phosphatidylinositol 3-kinase in cardiomyocyte differentiation of embryonic stem cells. FEBS Lett 2000; 476 (3): 218-23
62. Behfar A, Zingman LV, Hodgson DM, et al. Stem cell differentiation requires a paracrine pathway in the heart. Faseb J 2002; 16 (12): 1558-66
63. Yang Y, Min JY, Rana JS, et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 2002; 93 (3): 1140-51
64. Dell'Era P, Ronca R, Coco L, et al. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ Res 2003; 93 (5): 414-20
65. Hidaka K, Lee JK, Kim HS, et al. Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. Faseb J 2003; 17 (6): 740-2
66. Sachinidis A, Gissel C, Nierhoff D, et al. Identification of platelet-derived growth factor-BB as cardiogenesis-inducing factor in mouse embryonic stem cells under serum-free conditions. Cell Physiol Biochem 2003; 13 (6): 423-9
67. Rudy-Reil D, Lough J. Avian precardiac endoderm/mesoderm induces cardiac myocyte differentiation in murine embryonic stem cells. Circ Res 2004; 94 (12): e107-16
68. Kofidis T, de Bruin JL, Yamane T, et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 2004; 22 (7): 1239-45
69. Kanno S, Kim PK, Sallam K, et al. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci U S A 2004; 101 (33): 12277-81
70. Kawamura T, Ono K, Morimoto T, et al. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem 2005; 280 (20): 19682-8
71. Honda M, Hamazaki TS, Komazaki S, et al. RXR agonist enhances the differentiation of cardiomyocytes derived from embryonic stem cells in serum-free conditions. Biochem Biophys Res Commun 2005; 333 (4): 1334-40
72. Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005; 366 (9490): 1005-12
73. Singla DK, Sun B. Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun 2005; 332 (1): 135-41
74. Czyz J, Guan K, Zeng Q, et al. Loss of beta 1 integrin function results in upregulation of connexin expression in embryonic stem cell-derived cardiomyocytes. Int J Dev Biol 2005; 49 (1): 33-41
75. Sachinidis A, Schwengberg S, Hippler-Altenburg R, et al. Identification of small signalling molecules promoting cardiac-specific differentiation of mouse embryonic stem cells. Cell Physiol Biochem 2006; 18 (6): 303-14
76. Zhu DY, Lou YJ. Icariin-mediated expression of cardiac genes and modulation of nitric oxide signaling pathway during differentiation of mouse embryonic stem cells into cardiomyocytes in vitro. Acta Pharmacol Sin 2006; 27 (3): 311-20
77. Bin Z, Sheng LG, Gang ZC, et al. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol Int 2006; 30 (10): 769-76
78. Chen Y, Shao JZ, Xiang LX, et al. Cyclic adenosine 3′,5′- monophosphate induces differentiation of mouse embryonic stem cells into cardiomyocytes. Cell Biol Int 2006; 30 (4): 301-7
79. E LL, Zhao YS, Guo XM, et al. Enrichment of cardiomyocytes derived from mouse embryonic stem cells. J Heart Lung Transplant 2006; 25 (6): 664-74
80. Ding L, Liang X, Zhu D, et al. Peroxisome proliferator-activated receptor alpha is involved in cardiomyocyte differentiation of murine embryonic stem cells in vitro. Cell Biol Int 2007; 31 (9): 1002-9
81. Singh AM, Li FQ, Hamazaki T, et al. Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells. Circulation 2007; 115 (5): 617-26
82. Hatami L, Valojerdi MR, Mowla SJ. Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells. Int J Cardiol 2007; 117 (1): 80-9
83. Khezri S, Valojerdi MR, Sepehri H, et al. Effect of basic fibroblast growth factor on cardiomyocyte differentiation from mouse embryonic stem cells. Saudi Med J 2007; 28 (2): 181-6
84. Taha MF, Valojerdi MR, Mowla SJ. Effect of bone morphogenetic protein-4 (BMP-4) on cardiomyocyte differentiation from mouse embryonic stem cell. Int J Cardiol 2007; 120 (1): 92-101
85. Hofner M, Hollrigl A, Puz S, et al. Desmin stimulates differentiation of cardiomyocytes and up-regulation of brachyury and nkx2.5. Differentiation 2007; 75 (7): 605-15
86. Roggia C, Ukena C, Bohm M, et al. Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase. Exp Cell Res 2007; 313 (5): 921-30
87. Bugorsky R, Perriard JC, Vassalli G. N-cadherin is essential for retinoic acid-mediated cardiomyogenic differentiation in mouse embryonic stem cells. Eur J Histochem 2007; 51 (3): 181-92
88. Behfar A, Perez-Terzic C, Faustino RS, et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 2007; 204 (2): 405-20
89. Kim HS, Cho JW, Hidaka K, et al. Activation of MEK-ERK by heregulin-beta1 promotes the development of cardiomyocytes derived from ES cells. Biochem Biophys Res Commun 2007; 361 (3): 732-8
90. Gassanov N, Devost D, Danalache B, et al. Functional activity of the carboxylterminally extended oxytocin precursor peptide during cardiac differentiation of embryonic stem cells. Stem Cells 2008; 26 (1): 45-54
91. Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2000; 97 (21): 11307-12
92. Xu C, Police S, Rao N, et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 91 (6): 501-8
93. Mummery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 2003; 107 (21): 2733-40
94. Passier R, Oostwaard DW, Snapper J, et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 2005; 23 (6): 772-80
95. McDevitt TC, Laflamme MA, Murry CE. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 2005; 39 (6): 865-73
96. Xu C, He JQ, Kamp TJ, et al. Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev 2006; 15 (6): 931-41
97. Yoon BS, Yoo SJ, Lee JE, et al. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 2006; 74 (4): 149-59
98. Mujoo K, Krumenacker JS, Wada Y, et al. Differential expression of nitric oxide signaling components in undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev 2006; 15 (6): 779-87
99. Pal R, Khanna A. Similar pattern in cardiac differentiation of human embryonic stem cell lines, BG01V and ReliCellhES1, under low serum concentration supplemented with bone morphogenetic protein-2. Differentiation 2007; 75 (2): 112-22
100. Tomescot A, Leschik J, Bellamy V, et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 2007; 25 (9): 2200-5
101. Bettiol E, Sartiani L, Chicha L, et al. Fetal bovine serum enables cardiac differentiation of human embryonic stem cells. Differentiation 2007; 75 (8): 669-81
102. Graichen R, Xu X, Braam SR, et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008; 76 (4): 357-70
103. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25 (9): 1015-24
104. He JQ, Ma Y, Lee Y, et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003; 93 (1): 32-9
105. Anderson D, Self T, Mellor IR, et al. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 2007; 15 (11): 2027-36
106. Reppel M, Boettinger C, Hescheler J. Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 2004; 14 (4-6): 187-96
107. Fijnvandraat AC, van Ginneken AC, de Boer PA, et al. Cardiomyocytes derived from embryonic stem cells resemble cardiomyocytes of the embryonic heart tube. Cardiovasc Res 2003; 58 (2): 399-409
108. Fijnvandraat AC, van Ginneken AC, Schumacher CA, et al. Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J Mol Cell Cardiol 2003; 35 (12): 1461-72
109. Dolnikov K, Shilkrut M, Zeevi-Levin N, et al. Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 2006; 24 (2): 236-45
110. Dolnikov K, Shilkrut M, Zeevi-Levin N, et al. Functional properties of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 2005; 1047: 66-75
111. Liu J, Fu JD, Siu CW, et al. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 2007; 25 (12): 3038-44
112. Fu JD, Li J, Tweedie D, et al. Crucial role of the sarcoplasmic reticulum in the developmental regulation of Ca2+ transients and contraction in cardiomyocytes derived from embryonic stem cells. Faseb J 2006; 20 (1): 181-3
113. Fu JD, Yu HM, Wang R, et al. Developmental regulation of intracellular calcium transients during cardiomyocyte differentiation of mouse embryonic stem cells. Acta Pharmacol Sin 2006; 27 (7): 901-10
114. Zhang YM, Hartzell C, Narlow M, et al. Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation 2002; 106 (10): 1294-9
115. Valderrabano M, Chen F, Dave AS, et al. Atrioventricular ring reentry in embryonic mouse hearts. Circulation 2006; 114 (6): 543-9
116. Segev H, Kenyagin-Karsenti D, Fishman B, et al. Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Dev Growth Differ 2005; 47 (5): 295-306
117. Kolossov E, Bostani T, Roell W, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med 2006; 203 (10): 2315-27
118. Huber I, Itzhaki I, Caspi O, et al. Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. Faseb J 2007; 21 (10): 2551-63
119. Lyons GE, Ontell M, Cox R, et al. The expression of myosin genes in developing skeletal muscle in the mouse embryo. J Cell Biol 1990; 111 (4): 1465-76
120. Franco D, Markman MM, Wagenaar GT, et al. Myosin light chain 2a and 2v identifies the embryonic outflow tract myocardium in the developing rodent heart. Anat Rec 1999; 254 (1): 135-46
121. Ng WA, Grupp IL, Subramaniam A, et al. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res 1991; 68 (6): 1742-50
122. Siedner S, Kruger M, Schroeter M, et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 2003; 548 (Pt 2): 493-505
123. Nir SG, David R, Zaruba M, et al. Human embryonic stem cells for cardiovascular repair. Cardiovasc Res 2003; 58 (2): 313-23
124. Moretti A, Caron L, Nakano A, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006; 127 (6): 1151-65
125. Wu SM, Fujiwara Y, Cibulsky SM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006; 127 (6): 1137-50
126. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006; 11 (5): 723-32
127. Min JY, Yang Y, Converso KL, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 2002; 92 (1): 288-96
128. Min JY, Yang Y, Sullivan MF, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003; 125 (2): 361-9
129. Hodgson DM, Behfar A, Zingman LV, et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 287 (2): H471-9
130. Himes N, Min JY, Lee R, et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 2004; 52 (5): 1214-9
131. Kofidis T, de Bruin JL, Hoyt G, et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 2004; 128 (4): 571-8
132. Naito H, Nishizaki K, Yoshikawa M, et al. Xenogeneic embryonic stem cellderived cardiomyocyte transplantation. Transplant Proc 2004; 36 (8): 2507-8
133. Swijnenburg RJ, Tanaka M, Vogel H, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005; 112 (9 Suppl.): I166-72
134. Min JY, Huang X, Xiang M, et al. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg 2006; 131 (4): 889-97
135. Kofidis T, de Bruin JL, Yamane T, et al. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation 2005; 111 (19): 2486-93
136. Johkura K, Cui L, Yue F, et al. Natriuretic peptides in ectopic myocardial tissues originating from mouse embryonic stem cells. Microsc Res Tech 2005; 66 (4): 165-72
137. Malek S, Kaplan E, Wang JF, et al. Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflugers Arch 2006; 452 (3): 268-75
138. Singla DK, Hacker TA, Ma L, et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 2006; 40 (1): 195-200
139. Nelson TJ, Ge ZD, Van Orman J, et al. Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A Discov Mol Cell Evol Biol 2006; 288 (11): 1216-24
140. Nussbaum J, Minami E, Laflamme MA, et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J 2007; 21 (7): 1345-57
141. Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 2007; 293 (2): H1308-14
142. Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24 (2): 221-9
143. Tian L, Catt JW, O'Neill C, et al. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol Reprod 1997; 57 (3): 561-8
144. Laflamme MA, Gold J, Xu C, et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005; 167 (3): 663-71
145. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005; 111 (1): 11-20
146. Kofidis T, Lebl DR, Swijnenburg RJ, et al. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg 2006; 29 (1): 50-5
147. Leor J, Gerecht S, Cohen S, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007; 93 (10): 1278-84
148. van Laake LW, Passier R, Monshouwer-Kloots J, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007; 1: 9-24
149. Dai W, Field LJ, Rubart M, et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 2007; 43 (4): 504-16
150. Pillekamp F, Reppel M, Rubenchyk O, et al. Force measurements of human embryonic stem cell-derived cardiomyocytes in an in vitro transplantation model. Stem Cells 2007; 25 (1): 174-80
151. Reinecke H, Murry CE. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol 2002; 34 (3): 251-3
152. Elliott DA, Harvey RP. Time to mend a broken heart. Stem Cell Res 2007; 1: 4-6
153. Rubart M, Field LJ. ES cells for troubled hearts. Nat Biotechnol 2007; 25 (9): 993-4